NCT02247947已完成不适用
Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- death at day 20
研究概览
简要总结
Proteomics is used to identify prognostic markers after CPR. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.
详细描述
Proteomics is used to identify prognostic markers after CPR, i.e. altered proteins on a 2G-gel. Additionally neurological outcome should be estimated by specific protein alterations and affections of pathways.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •cardiac arrest
排除标准
- 未提供
结局指标
主要结局
death at day 20
时间窗: day 20
次要结局
未报告次要终点
研究者
Jochen Hinkelbein
Priv.-Doz. Dr. med.
Universitätsklinikum Köln
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal CancerEsophageal CancerNCT00911092Centre Oscar Lambret50
Unknown
不适用
Circulating Biomarkers Predict Neurological Outcome After Cardiac ArrestCardiac ArrestNCT02297776Shanghai 10th People's Hospital160
终止
不适用
Neuroimaging & Plasma Markers for Predicting Outcomes After Mild Traumatic Brain InjuryTraumatic Brain InjuryInjury of Body RegionNCT02891941Johns Hopkins University10
终止
不适用
Biochemical Makers for Outcome After Pediatric out-of Hospital Cardiac ArrestOut-Of-Hospital Cardiac ArrestNCT03873662Brno University Hospital4
终止
不适用
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell CarcinomaCarcinoma, Squamous CellCarcinoma, SquamousLung NeoplasmsCancer of LungCancer of the LungNeoplasms, LungNeoplasms, PulmonaryPulmonary CancerPulmonary NeoplasmsLung CancerSquamous Cell CarcinomaNCT02549638Mayo Clinic22